Thompson Siegel & Walmsley’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Thompson Siegel & Walmsley’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-103,272	Closed	-$5.46M	–	700
2020 Q3	$5.46M	Buy	103,272 +20,468	+25%	+$1.26M	0.11%	153
2020 Q2	$5.07M	Sell	82,804 -948	-1%	-$54.8K	0.1%	150
2020 Q1	$4.74M	Buy	83,752 +1,532	+2%	+$87.3K	0.11%	144
2019 Q4	$4.68M	Buy	82,220 +64,758	+371%	+$3.43M	0.07%	172
2019 Q3	$935K	Buy	+17,462	New	+$1.02M	0.01%	263

Other funds holding BSTC

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Thompson Siegel & Walmsley's BSTC Position: Q4 2020 in Review

Thompson Siegel & Walmsley sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 103,272 shares — an estimated $5.46M sold.

Thompson Siegel & Walmsley first reported a position in BSTC in Q3 2019 and held it in 5 quarters. The position peaked at $5.46M in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Thompson Siegel & Walmsley reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Thompson Siegel & Walmsley sold 103,272 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $5.46M.
Thompson Siegel & Walmsley first reported a position in BioSpecifics Technologies Corp. in Q3 2019 and held it in 5 quarters.
Thompson Siegel & Walmsley's BioSpecifics Technologies Corp. position peaked at $5.46M in Q3 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2020, filed 8 Feb 2021.